What makes ENTICe unique is that it crosses the boundaries of traditional academic departments and scientific disciplines to focus on the specific goal of advancing research in neuromodulation and developing new and innovative neuromodulation devices.
ENTICe engages the changing dynamics of medical research, in which classic distinctions and barriers between basic science, clinical research, and engineering are blurred and removed, by formally organizing, integrating, coordinating, and supporting the research of scientists, biomedical engineers, clinicians, and others at Emory and its academic partners that are involved in the development and use of neuromodulation technologies for the treatment of neurologic and psychiatric diseases and disorders. The relationship among these groups is of critical importance as medical research and technology becomes more multi-disciplinary.
The collaborative environment at ENTICe allows for a fluid and seamless exchange of ideas and insights and also encourages new collaborations to develop among those researchers who have a shared interest in neuromodulation and neurotechnology and their applications. ENTICe serves as a shared platform for research and translational neuroscience advancements where knowledge, technical assistance, and funds are systematically distributed throughout the program.
The Emory and Georgia Tech Partnership
ENTICe physician scientists are internationally known pioneers for the development of clinical neuromodulation treatments, particularly deep brain stimulation, and INTENT scientists have a strong record of using engineering approaches such as neural interfacing, neural signal analysis, neural simulation, and real-time manipulation of neural circuits for interfacing, to advance the quantitative understanding of neural function and neurotechnologies. In addition, Georgia Tech has expertise in technical and engineering disciplines that can support these activities with experts in control theory, microfabrication, and neural regeneration and biomaterials - all critical to advance brain stimulation treatments.
The technological strengths of the Georgia Tech team are complementary to the clinical research strengths of the Emory team, creating a relationship that is scientifically beneficial. The combination of Georgia Tech engineering and Emory biomedical and clinical research will 1) allow for the development of novel approaches to advance existing neuromodulation treatments, 2) generate ideas for new devices and treatments that can be brought from bench to bedside, and 3) help establish the mechanism of why particular treatments do or do not succeed. Together, through the integration of our respective programs and by directing our resources and efforts, we are poised to become world-leaders in areas related to the advancement of neuromodulation treatments and neuroscience research.
Our Relationships
Connect with our partners at Emory University and Georgia Tech including others in our community.
ENTICe: Vision, Mission, and Goals
Vision
To maintain and strengthen our position among the world leaders in neuromodulation by extending our work into new areas of clinical and research innovation through the development of a unique model for discovery, education, and care.
Mission
The mission of the Emory Neuromodulation and Technology Innovation Center (ENTICe) is to propel neuromodulation innovation upon a “three-legged stool” comprised of clinicians/scientists, engineers, and industry all of whom work closely together to develop new ideas and solve critical hurdles to neuromodulation therapy for neurological and psychiatric disorders.
Goals
- Establish a cultural model of inclusivity and openness that encourages involvement and new collaborations among basic scientists, engineers, and clinical researchers across Emory and its academic partners with shared interest in neuromodulation, and innovative neuromodulation technologies and their application.
- Develop new models of training in interdisciplinary research and technology development for graduate students, post-doctoral fellows, faculty scientists, and clinicians.
- Develop innovative treatment solutions using device technologies for neurological and psychiatric disorders through new basic science and clinical collaborations.
- Translate innovative technologies into pilot clinical trials that lead to new models of patient care.